iNtRON Biotechnology Inc Cash Flow Quality Index
iNtRON Biotechnology Inc cash flow quality index. iNtRON Biotechnology Inc (048530) has a Cash Flow Quality Index of -4.73x as of June 2024. Operating cash flow of ₩-2.74 Billion is below net income of ₩579.25 Million, suggesting accrual-heavy earnings not yet converted to cash. See iNtRON Biotechnology Inc (048530) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of iNtRON Biotechnology Inc (2015–2022)
Cash flow quality index of iNtRON Biotechnology Inc from 2015 to 2022. Historical Cash Flow Quality Index for iNtRON Biotechnology Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore iNtRON Biotechnology Inc (048530) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
iNtRON Biotechnology Inc Cash Flow Quality Index by Year (2015–2022)
iNtRON Biotechnology Inc cash flow quality index by year from 2015 to 2022. Year-by-year earnings quality comparison for iNtRON Biotechnology Inc. For the full cash flow conversion analysis, see iNtRON Biotechnology Inc cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.05x | ₩5.98 Billion | ₩5.71 Billion | ▼ -38.2% |
| 2021 | 1.69x | ₩16.47 Billion | ₩9.73 Billion | ▲ +255.0% |
| 2020 | 0.48x | ₩7.13 Billion | ₩14.95 Billion | ▼ -1.1% |
| 2018 | 0.48x | ₩4.20 Billion | ₩8.71 Billion | ▼ -55.8% |
| 2015 | 1.09x | ₩1.70 Billion | ₩1.56 Billion | — |